top of page
Medex EU Authorised Representative logo

EU Authorized Representative for Surgical Suture Manufacturers: Rules 7, 8 and 18 and the Mandate

Surgical sutures are surgically invasive devices under Regulation (EU) 2017/745, and their class turns on two facts: whether the suture is absorbed and how long it is intended to stay. A non-absorbable skin suture removed within 30 days is class IIa under Rule 7, a non-absorbable internal suture is class IIb under Rule 8, and any absorbable suture is class III. A suture manufacturer established outside the Union must designate a sole authorized representative under Article 11, and one mandate covers the EU and Türkiye.

Absorbable or not, and for how long: the two questions Annex VIII asks

A suture is a surgically invasive device: it is placed through the surface of the body in the context of a surgical operation. Its class depends on whether it is absorbed and how long it is intended to stay. MDCG 2021-24 stresses that intended purpose, not material, decides, and gives the example of two sutures of the same composition with different intended purposes and therefore different classes.

Short-term sutures: Rule 7

A suture intended to be removed within 30 days, typically a skin suture, is a surgically invasive device for short-term use:

"All surgically invasive devices intended for short-term use are classified as class IIa unless they:" (MDR Annex VIII, Rule 7)

  • "are intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with those parts of the body, in which case they are classified as class III;"
  • "have a biological effect or are wholly or mainly absorbed in which case they are classified as class III;"

MDCG 2021-24 lists absorbable sutures under the biological effect indent of Rule 7, class III, and skin closure devices as class IIa. A non-absorbable skin suture removed within 30 days is therefore class IIa; an absorbable suture is class III because it is wholly or mainly absorbed; a suture used specifically to correct a defect of the heart or of the central circulatory system is class III under the first indent.

Long-term and internal sutures: Rule 8

A suture left in the body for more than 30 days is a long-term surgically invasive device, and a buried suture that remains after the procedure is an implantable device under Article 2(5). Rule 8 applies:

"All implantable devices and long-term surgically invasive devices are classified as class IIb unless they:" (MDR Annex VIII, Rule 8)

  • "are intended to be used in direct contact with the heart, the central circulatory system or the central nervous system, in which case they are classified as class III;"
  • "have a biological effect or are wholly or mainly absorbed, in which case they are classified as class III;"

MDCG 2021-24 lists non-absorbable sutures as class IIb under the general rule, cardiovascular sutures as class III under the second indent and long term absorbable sutures as class III under the third indent.

Sutures of animal origin: Rule 18

"All devices manufactured utilising tissues or cells of human or animal origin, or their derivatives, which are non-viable or rendered non-viable, are classified as class III, unless such devices are manufactured utilising tissues or cells of animal origin, or their derivatives, which are non-viable or rendered non-viable and are devices intended to come into contact with intact skin only." (MDR Annex VIII, Rule 18)

A suture never contacts intact skin only, so catgut or collagen sutures are class III whatever their duration; Regulation (EU) No 722/2012 applies in addition for the species it covers.

Is a suture an implant, and does the implant card apply?

"Nor would a suture used for skin wound closure that is intended to be taken out prior to 30 days be considered an implant." (MDCG 2021-24, Section 3.1, implantable devices)

A buried, non-absorbable suture that stays after the procedure is an implant. Article 18 then applies in principle, but its third paragraph removes sutures from the implant card:

"The following implants shall be exempted from the obligations laid down in this Article: sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors." (MDR Article 18(3))

The same list in Article 52(4) spares sutures the per-device technical documentation assessment that other class IIb implants receive:

"However, for class IIb implantable devices, except sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors, the assessment of the technical documentation as specified in Section 4 of Annex IX shall apply for every device." (MDR Article 52(4), second subparagraph)

Article 32 is not spared: an implantable suture needs a summary of safety and clinical performance validated by the notified body, and Article 10(8) extends document retention to 15 years.

Suture needles and needle-suture combinations

The swaged needle is classified in its own right under Section 3.2 and falls under Rule 6; MDCG 2021-24 lists needles used for suturing as class IIa. Under Section 3.5 a needle-suture combination placed on the market as one device takes the stricter class, which is the class of the suture. A suture packed into a procedure pack is covered by Article 22; see our note on systems and procedure packs.

Classification table for a suture range

Product variantClassRuleNotified body
Non-absorbable skin suture removed within 30 daysIIaRule 7Yes
Absorbable suture, absorbed within 30 daysIIIRule 7, biological effect indentYes
Non-absorbable internal suture remaining more than 30 daysIIbRule 8Yes; SSCP, no implant card, no per-device TD assessment
Long-term absorbable sutureIIIRule 8, biological effect indentYes; Article 54 consultation
Cardiovascular suture; suture contacting the central nervous systemIIIRule 7 or 8, central circulatory or nervous system indentsYes
Suture of animal origin (catgut, collagen)IIIRule 18Yes; Regulation (EU) No 722/2012
Suture with an antimicrobial coating that is a medicinal substanceIIIRule 14Yes; medicines authority consultation

Conformity assessment for class III sutures

"Manufacturers of class III devices, other than custom-made or investigational devices, shall be subject to a conformity assessment as specified in Annex IX. Alternatively, the manufacturer may choose to apply a conformity assessment as specified in Annex X coupled with a conformity assessment as specified in Annex XI." (MDR Article 52(3))

For class III implantable sutures the notified body follows the Article 54 consultation procedure, and the clinical evaluation must address absorption profile and tensile strength retention for each intended site. Class IIb sutures follow Article 52(4).

What the authorized representative mandate covers for surgical sutures

The appointment turns on where the manufacturer is established, not on the class of the device:

"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative." (MDR Article 11(1))

Article 11(3) fixes the minimum tasks:

"The mandate shall require, and the manufacturer shall enable, the authorised representative to perform at least the following tasks in relation to the devices that it covers:" (MDR Article 11(3))

  • "keep available a copy of the technical documentation, the EU declaration of conformity and, if applicable, a copy of the relevant certificate, including any amendments and supplements, issued in accordance with Article 56, at the disposal of competent authorities for the period referred to in Article 10(8);"
  • "terminate the mandate if the manufacturer acts contrary to its obligations under this Regulation."

For a suture manufacturer the representative checks that the Basic UDI-DI structure separates absorbable from non-absorbable lines and keeps the documentation available for 15 years after the last implantable suture is placed on the market.

One mandate for the European Union and Türkiye

Medex Kurumsal Danışmanlık acts as EU authorized representative under EUDAMED SRN TR-AR-000057550, with offices in Ankara and İstanbul. A manufacturer of surgical sutures established outside the EU and Türkiye does not need two representatives:

"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey." (European Commission, Notice to Stakeholders, EU-Turkey Customs Union Agreement in the field of medical devices, March 2022, section I.2)

"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey." (MDCG 2022-16, footnote 1)

Our mandate covers the EU Member States and Türkiye; we are not a Swiss representative or UK Responsible Person, not a notified body, and we do not find importers or distributors. The published bands on our pricing page are €1,000 to 1,300 per year for class IIa, €1,200 to 1,600 per year for class IIb, €1,500 to 2,000 per year for class III, with a €0 setup fee and rates fixed for three years from signature. Registration of the same surgical sutures in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, is a separate service: ÜTS registration of surgical sutures in Türkiye (Turkish).

The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.

Related device categories and country pages

Related groups: reusable surgical instruments, wound dressings and orthopedic implants. All groups are listed on the medical device categories page, and the manufacturer country pages start from the EU authorized representative by country list.

Frequently asked questions

Which class is an absorbable suture?

Class III. Rule 7 places a short-term surgically invasive device that is wholly or mainly absorbed in class III, and Rule 8 does the same for a long-term one. MDCG 2021-24 lists absorbable sutures under Rule 7 and long term absorbable sutures under Rule 8.

Is a non-absorbable skin suture class IIa?

Yes, where it is intended to be removed within 30 days. It is a short-term surgically invasive device under Rule 7 and no indent applies. The same suture left in place internally for more than 30 days is class IIb under Rule 8.

Does a suture need an implant card?

No. Article 18(3) exempts sutures from the implant card obligations. An implantable suture still needs the summary of safety and clinical performance under Article 32.

Which class is catgut?

Class III under Rule 18, because it is manufactured utilising tissues of animal origin and a suture does not contact intact skin only. Regulation (EU) No 722/2012 applies in addition for the animal species it covers.

Does one mandate cover the European Union and Türkiye?

Yes. The European Commission's Notice of March 2022 states that a manufacturer established outside the EU and Türkiye only needs one authorized representative, established in the EU or in Türkiye. Medex is established in Türkiye under EUDAMED SRN TR-AR-000057550.

Sources and further reading

Regulation (EU) 2017/745 on medical devices (MDR), Articles 2, 10, 11, 18, 32, 52 and 54, Annex VIII - eur-lex.europa.eu

MDCG 2021-24, Guidance on classification of medical devices (October 2021) - health.ec.europa.eu

MDCG 2022-16, Guidance on authorised representatives (Regulation (EU) 2017/745 and Regulation (EU) 2017/746) - health.ec.europa.eu

European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022) - health.ec.europa.eu

Get a fixed-price EU REP quote for your suture range (reply within 1 business day).

Request a proposal  ·  View pricing  ·  Our EU REP service

bottom of page